This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Cryoport, Inc. ("the Company"), the leading provider of advanced cryogenic logistics solutions, partners with LifeConEx, a part of DHL Global Forwarding, to enhance and supplement DHL's cold chain logistics offerings including DHL Express' Medical Express to its life sciences and healthcare customers with Cryoport's comprehensive cryogenic logistics solutions.
http://photos.prnewswire.com/prnvar/20140401/NY95107LOGO
With these new services, DHL is now offering advanced cryogenic logistics solutions as well as the best-in-class solution for shipping temperature-sensitive products and biological materials in a cryogenic state to its life sciences and healthcare customers.
DHL Global Forwarding currently has 45 Certified Life Sciences stations around the world and they have stated that they will end the year with 65 integrated stations. These forwarding stations as well as dedicated life sciences warehouses and clinical trial depots will now be able to rely on Cryoport for cryogenic shipping. Cryoport believes this is an important element of DHL's strategy to increase their business in temperature-controlled shipping. As DHL's research has reported, the worldwide shipping volume in the cold chain tripled from $56 billion in 2004 to $167 billion in 2013. As life sciences products become more complex the need for Cryoport's solutions becomes more strategic.
Integral parts of this new service include the Cryoport Express(®) Shippers that use a dry vapor liquid nitrogen technology, providing 10 days of holding time at minus 150 degrees C, under dynamic shipping conditions combined with temperature monitoring throughout the shipping process. Cryoport's solutions offer a superior, more reliable alternative to dry ice, which needs to be re-iced every few days creating conditions for temperature excursions. This is of particular importance for the shipments of fragile biomaterials. In addition, Cryoport solutions are also more economical and less hazardous than liquid nitrogen.
"As the life sciences industry continues to transform and evolve to meet growing demands for reliable frozen shipping solutions, we are thrilled to be combining forces with Cryoport," stated David Y. Bang, CEO of LifeConEx. "We are especially impressed with Cryoport's ability to maintain and monitor customers' highly sensitive biologic materials in a temperature-controlled, cryogenic environment, throughout the entire shipment process. Our uniquely combined solution alleviates the concerns of damaged or lost materials, given the access to its temperature monitoring system, which records the chain of condition throughout each shipment."
Jerrell Shelton, Chief Executive Officer of Cryoport, stated, "This partnership with DHL is an important step in furthering our reach into the life sciences total addressable market. Our solutions were very well received at 14th annual DHL Life Sciences & Healthcare Global Conference in Shanghai, China, where our solution and its benefits were presented to DHL's life sciences and healthcare attendees. As a pioneer for logistics solutions and a leader in cold chain solutions for life sciences, DHL stands at the forefront of delivering advanced temperature-controlled solutions to every segment of the ever-growing life sciences community. We are proud to support the DHL strategy in life sciences as they move forward and advance their offerings on a global basis."
